Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-021-03119-8.

Title:
Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice | Cancer Immunology, Immunotherapy
Description:
Abstract Transmembrane protein GARP binds latent TGF-β1 to form GARP:(latent)TGF-β1 complexes on the surface of several cell types including Tregs, B-cells, and platelets. Upon stimulation, these cells release active TGF-β1. Blocking TGF-β1 activation by Tregs with anti-GARP:TGF-β1 mAbs overcomes resistance to PD1/PD-L1 blockade and induces immune-mediated regressions of murine tumors, indicating that Treg-derived TGF-β1 inhibits anti-tumor immunity. TGF-β1 exerts a vast array of effects on immune responses. For example, it favors differentiation of TH17 cells and B-cell switch to IgA production, two important processes for mucosal immunity. Here, we sought to determine whether treatment with anti-GARP:TGF-β1 mAbs would perturb immune responses to intestinal bacterial infection. We observed no aggravation of intestinal disease, no systemic dissemination, and no alteration of innate or adaptative immune responses upon oral gavage of C. rodentium in highly susceptible Il22r−/− mice treated with anti-GARP:TGF-β1 mAbs. To examine the effects of GARP:TGF-β1 blockade on Ig production, we compared B cell- and TH cell- responses to OVA or CTB protein immunization in mice carrying deletions of Garp in Tregs, B cells, or platelets. No alteration of adaptive immune responses to protein immunization was observed in the absence of GARP on any of these cells. Altogether, we show that antibody-mediated blockade of GARP:TGF-β1 or genetic deletion of Garp in Tregs, B cells or platelets, do not alter innate or adaptive immune responses to intestinal bacterial infection or protein immunization in mice. Anti-GARP:TGF-β1 mAbs, currently tested for cancer immunotherapy, may thus restore anti-tumor immunity without severely impairing other immune defenses. Précis Immunotherapy with GARP:TGF-β1 mAbs may restore anti-tumor immunity without impairing immune or inflammatory responses required to maintain homeostasis or host defense against infection, notably at mucosal barriers.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Pets

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

mice, cells, antigarptgfβ, rodentium, pubmed, article, tgfβ, mabs, fig, responses, infection, google, scholar, immune, cell, cas, iga, garp, immunization, day, ova, pbs, protein, tregs, intestinal, bacterial, production, mouse, innate, adaptive, igm, data, observed, igg, days, immunity, ilr, gavage, garptgfβ, ctb, expression, performed, weight, measured, central, complexes, disease, supplementary, activation, blockade,

Topics {✒️}

mann–whitney unpaired t-test para-phenylenediamine-induced contact hypersensitivity exclude cell-type-restricted effects tgf-beta-directed iga switching anti-il-17a auto-vaccine garp/latent tgf-beta1 complexes tgf-beta receptor controls article download pdf cell-type-specific garp kos garp/tgf-beta1 complexes inhibit latent tgf-beta structure induces immune-mediated regressions active tgf-beta1 released latent tgf-beta1 presentation neutralizes active tgf-β1 active tgf-β1 released pd-1/pd-l1 blockade ova-specific ab responses permit number 2017/ucl/md/019 mature tgf-β1 dimer releasing mature tgf-β1 enhances citrobacter-induced colitis cell-type-specific knock pd1/pd-l1 blockade anti-tgf-β mabs 1 day induce immune-mediated regressions tgf-β receptor chains restore anti-tumor immunity restoring anti-tumor immunity tgf-β1 mabs tend exert anti-tumor effects specific cre-mediated deletion garp/tgf-beta1 complexes mm-long terminal fragments cell-dependent serum antibody treg-specific garp kos full size image active tgf-β1 required blocking tgf-β1 activation block tgf-β1 activation blocking garp-mediated activation tgf-β1 mabs survived anti-tgf-β mab latent tgf-beta bonferroni post-test mice receiving anti-garp measure ctb specific-igs antibody-mediated blockade treg garp-expressing cells murine il-17a elisa

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice
         description:Transmembrane protein GARP binds latent TGF-β1 to form GARP:(latent)TGF-β1 complexes on the surface of several cell types including Tregs, B-cells, and platelets. Upon stimulation, these cells release active TGF-β1. Blocking TGF-β1 activation by Tregs with anti-GARP:TGF-β1 mAbs overcomes resistance to PD1/PD-L1 blockade and induces immune-mediated regressions of murine tumors, indicating that Treg-derived TGF-β1 inhibits anti-tumor immunity. TGF-β1 exerts a vast array of effects on immune responses. For example, it favors differentiation of TH17 cells and B-cell switch to IgA production, two important processes for mucosal immunity. Here, we sought to determine whether treatment with anti-GARP:TGF-β1 mAbs would perturb immune responses to intestinal bacterial infection. We observed no aggravation of intestinal disease, no systemic dissemination, and no alteration of innate or adaptative immune responses upon oral gavage of C. rodentium in highly susceptible Il22r−/− mice treated with anti-GARP:TGF-β1 mAbs. To examine the effects of GARP:TGF-β1 blockade on Ig production, we compared B cell- and TH cell- responses to OVA or CTB protein immunization in mice carrying deletions of Garp in Tregs, B cells, or platelets. No alteration of adaptive immune responses to protein immunization was observed in the absence of GARP on any of these cells. Altogether, we show that antibody-mediated blockade of GARP:TGF-β1 or genetic deletion of Garp in Tregs, B cells or platelets, do not alter innate or adaptive immune responses to intestinal bacterial infection or protein immunization in mice. Anti-GARP:TGF-β1 mAbs, currently tested for cancer immunotherapy, may thus restore anti-tumor immunity without severely impairing other immune defenses. Immunotherapy with GARP:TGF-β1 mAbs may restore anti-tumor immunity without impairing immune or inflammatory responses required to maintain homeostasis or host defense against infection, notably at mucosal barriers.
         datePublished:2022-01-01T00:00:00Z
         dateModified:2022-01-01T00:00:00Z
         pageStart:1851
         pageEnd:1862
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00262-021-03119-8
         keywords:
            GARP
            TGF-β1
            Monoclonal antibody
            Intestinal bacterial infections
             Citrobacter rodentium
            Protein immunization
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig5_HTML.png
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:71
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mélanie Gaignage
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xuhao Zhang
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Julie Stockis
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olivier Dedobbeleer
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Camille Michiels
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Perrine Cochez
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laure Dumoutier
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pierre G. Coulie
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
                     name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
                     address:
                        name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sophie Lucas
               url:http://orcid.org/0000-0003-1287-7996
               affiliation:
                     name:Université Catholique de Louvain
                     address:
                        name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
                     name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
                     address:
                        name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice
      description:Transmembrane protein GARP binds latent TGF-β1 to form GARP:(latent)TGF-β1 complexes on the surface of several cell types including Tregs, B-cells, and platelets. Upon stimulation, these cells release active TGF-β1. Blocking TGF-β1 activation by Tregs with anti-GARP:TGF-β1 mAbs overcomes resistance to PD1/PD-L1 blockade and induces immune-mediated regressions of murine tumors, indicating that Treg-derived TGF-β1 inhibits anti-tumor immunity. TGF-β1 exerts a vast array of effects on immune responses. For example, it favors differentiation of TH17 cells and B-cell switch to IgA production, two important processes for mucosal immunity. Here, we sought to determine whether treatment with anti-GARP:TGF-β1 mAbs would perturb immune responses to intestinal bacterial infection. We observed no aggravation of intestinal disease, no systemic dissemination, and no alteration of innate or adaptative immune responses upon oral gavage of C. rodentium in highly susceptible Il22r−/− mice treated with anti-GARP:TGF-β1 mAbs. To examine the effects of GARP:TGF-β1 blockade on Ig production, we compared B cell- and TH cell- responses to OVA or CTB protein immunization in mice carrying deletions of Garp in Tregs, B cells, or platelets. No alteration of adaptive immune responses to protein immunization was observed in the absence of GARP on any of these cells. Altogether, we show that antibody-mediated blockade of GARP:TGF-β1 or genetic deletion of Garp in Tregs, B cells or platelets, do not alter innate or adaptive immune responses to intestinal bacterial infection or protein immunization in mice. Anti-GARP:TGF-β1 mAbs, currently tested for cancer immunotherapy, may thus restore anti-tumor immunity without severely impairing other immune defenses. Immunotherapy with GARP:TGF-β1 mAbs may restore anti-tumor immunity without impairing immune or inflammatory responses required to maintain homeostasis or host defense against infection, notably at mucosal barriers.
      datePublished:2022-01-01T00:00:00Z
      dateModified:2022-01-01T00:00:00Z
      pageStart:1851
      pageEnd:1862
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00262-021-03119-8
      keywords:
         GARP
         TGF-β1
         Monoclonal antibody
         Intestinal bacterial infections
          Citrobacter rodentium
         Protein immunization
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-021-03119-8/MediaObjects/262_2021_3119_Fig5_HTML.png
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:71
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mélanie Gaignage
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xuhao Zhang
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Julie Stockis
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olivier Dedobbeleer
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Camille Michiels
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Perrine Cochez
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laure Dumoutier
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pierre G. Coulie
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
                  name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
                  address:
                     name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sophie Lucas
            url:http://orcid.org/0000-0003-1287-7996
            affiliation:
                  name:Université Catholique de Louvain
                  address:
                     name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
                  name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
                  address:
                     name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:71
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
      address:
         name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
         type:PostalAddress
      name:Université Catholique de Louvain
      address:
         name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
      address:
         name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mélanie Gaignage
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Xuhao Zhang
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Julie Stockis
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Olivier Dedobbeleer
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Camille Michiels
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Perrine Cochez
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Laure Dumoutier
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Pierre G. Coulie
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
            name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
            address:
               name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
               type:PostalAddress
            type:Organization
      name:Sophie Lucas
      url:http://orcid.org/0000-0003-1287-7996
      affiliation:
            name:Université Catholique de Louvain
            address:
               name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
            name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
            address:
               name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium
      name:de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
      name:Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium

External Links {🔗}(192)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.6s.